U.S. News & World Report (3/21, Howley) details how high breast density is both a risk factor for breast cancer and an impediment in mammograms. The “American College of Radiology classifies density into four categories: mostly fatty, scattered density, consistent density and extremely dense.” Dense breasts “can obscure or hide worrisome spots because the mammogram simply can’t see them through the denser tissue.” In addition, density “is an independent risk factor for breast cancer.”
Cancer Therapy Advisor (3/21, Primeau) reports that research suggests “for most patients with breast cancer, the benefits of modern radiotherapy outweigh the risks of future secondary malignancy and heart disease.” The findings were published in the Journal of Clinical Oncology.
In 2011, the FDA identified a possible association between breast implants and the development of anaplastic large cell lymphoma (ALCL), a rare type of non-Hodgkin's lymphoma. Since 2011, we have strengthened our understanding of this condition and concur with the World Health Organization designation of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) as a rare T-cell lymphoma that can develop following breast implants. Read more here.
Daniel Kopans, MD, FACR, FSBI, writes about "alternative facts" and the impact the concept has in breast imaging. He writes, "'Alternative Facts” (AF) recently appeared as an outrageous concept in the “political arena”. What most do not realize is that “alternative” facts have been promulgated for decades by those seeking to reduce access to breast cancer screening. This has led to the pseudo “debate” about screening that has persisted for decades due to the “alternative facts” that have been manufactured to keep the “debate” going. Each time an “alternative fact” has been generated to cast doubt on screening, it has been refuted by science ([i]). Unfortunately, as each (true) fact has been established, new “alternative facts” have been manufactured."